The mask, developed by Steven Lisco, MD, chair of the hospital’s anesthesiology department, features a face tent, positioned upside down with a viral filter attached, connected to wall suction unit that is then connected to a vacuum source.
The mask “caught more than 90 percent of airborne particles expelled… ultimately preventing the aerosol from entering the patient environment,” Dr. Lisco said.
The mask has been approved by the innovation committee at Nebraska Medicine, the hospital’s parent, and it is being deployed in operating room for use with asymptomatic patients undergoing monitored anesthesia care who may have COVID-19 and in the post-anesthesia care units.
COVID-19 patients can expel microscopic solid or liquid air particles, which can contaminate the patient’s environment. Patients also may produce the microscopic particles when asymptomatic or just before symptoms begin.
More articles on infection control:
Shortage of protective gear leads hospitals to buy and keep faulty N95 masks
Policies at Pennsylvania hospitals endangered patients, staff, whistleblowers say
Extended use of N95s is safer than reuse, ECRI suggests
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
